A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-06-30
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of HRS-7535 tablet in obese subjects.